Metformin and Glipizide are two widely used medications in the management of type 2 diabetes. As the prevalence of diabetes continues to rise globally, understanding the differences, benefits, and potential drawbacks of these medications is essential for patients, caregivers, and healthcare professionals alike. Both drugs function through distinct mechanisms to help control blood sugar levels, but their applications, efficacy, side effects, and patient experiences can vary significantly. Metformin, often viewed as a first-line treatment, works primarily by decreasing glucose production in the liver and increasing insulin sensitivity in muscle tissues. On the other hand, Glipizide belongs to a class of drugs known as sulfonylureas, which stimulate the pancreas to release…